Japan / Corporate network / historical acquisition
Nipro / JMI medical businesses
Nipro lists Bangladesh medical-device and pharmaceutical businesses.
Read the company evidence and original sourcesBangladesh / Industry evidence
Pharmaceuticals
Assess Pharmaceuticals opportunities in Bangladesh through finished pharmaceutical products, product distribution, manufacturing support services.
Evidence reviewed 1 November 2026.
What supports an investment assessment?
BIDA Heatmap: Immediate target
Promotion category from the January 2025 framework. It is not a market-demand measurement, approval, incentive entitlement or investment-return rating.
Read the official classificationMingdao analysis
Who would buy, and how would you serve them?
Qualified distributors, healthcare providers and manufacturers with product registrations and quality systems.
- Finished-dose production
- Licensed distribution
- Quality and technical partnerships
The opportunity becomes actionable when a customer need, a feasible delivery model and a tested cost base come together. Existing companies indicate activity, not automatic access to their orders.
The metrics your business case needs.
Use these as project measurements to collect. They are not published national performance statistics.
Registration milestones
Record the evidence, baseline, target and responsible verifier.
Batch acceptance
Record the evidence, baseline, target and responsible verifier.
Quality-system findings
Record the evidence, baseline, target and responsible verifier.
Stock availability
Record the evidence, baseline, target and responsible verifier.
What could change the outcome?
- Confirm formulation, dosage form and intended market.
- Verify GMP and product registration requirements.
- Separate finished medicines from API synthesis.
Prepare an investment decision file.
Provide target customers, intended business model, current evidence and assumptions. Include registration milestones, batch acceptance, quality-system findings, stock availability in the assessment.
Use the preparation checklistWhich country links are evidenced here?
Source documents and further reading.
Read the observation date and evidence status with each source. Company disclosures are attributed to the issuer. A reference to a policy is not a representation that a specific project qualifies for a benefit.
Nipro Corporation / Web
Nipro corporate network: Bangladesh businesses (opens in a new tab)
Undated corporate directory; checked 1 November 2026
Checked 1 November 2026. Read the issuer’s original publication.
Nipro Corporation / PDF
JMI Marketing subsidiary conversion announcement (opens in a new tab)
30 January 2020
Checked 1 November 2026. Read or save the original PDF in your browser.
BIDA / Invest Bangladesh / Web
FDI Heatmap sector classifications (opens in a new tab)
19 January 2025; investment-promotion framework
Checked 1 November 2026. Read the issuer’s original publication.
Make the next decision clearer
Scope your industry assessment.
Share your product, intended customer, business model and the assumptions you need to verify.
Foreign ownership in Bangladesh
Build a business you can fully own.
100% foreign ownership
Available in eligible sectors
100% foreign ownership is permitted in most sectors in Bangladesh. An eligible business can establish a wholly foreign-owned company without a local equity partner.
Eligibility depends on the business activity. Reserved or restricted activities, sector-specific ownership rules, licences and regulatory approvals must be checked before incorporation or investment.
Do I need a local shareholder?
For an activity eligible for wholly foreign-owned incorporation, a local equity partner is not generally required. The proposed activities and applicable sector rules must be reviewed first. Ownership eligibility does not replace company registration, operating licences or other required approvals.
Source: BIDA investment FAQ (opens in a new tab) · Checked 2 November 2026
Discuss your company setup